Epilepsy Epidemiology: Global Prevalence, Age Distribution, and Demographic Patterns
Epilepsy affects ~50 million people worldwide (~0.5–1% prevalence). It is one of the most common serious neurological disorders.
Age Distribution (Bimodal)
- Peak 1: Early childhood (<5 years). Febrile seizures, genetic epilepsies (SCN1A, etc.), congenital malformations, perinatal injury.
- Peak 2: Older adults (>65 years). Stroke, neurodegenerative disease, brain tumors, trauma, vascular malformations.
- Lowest incidence in adolescence/early adulthood.
Sex and Gender
Overall similar prevalence. Syndrome-specific differences:
- Childhood absence epilepsy, photosensitive epilepsy → more common in females.
- Juvenile myoclonic epilepsy, Lennox-Gastaut → more common in males.
Race/Ethnicity and Geography
- Higher prevalence in low- and middle-income countries (LMICs) — 2–3x high-income countries.
- Drivers: Neuroinfections (neurocysticercosis, malaria, meningitis), perinatal injury, limited prenatal care, trauma, genetic founder effects.
- In U.S., higher prevalence in Black and Hispanic populations vs. White — partly due to socioeconomic disparities, access to care, and comorbidity burden.
Etiologic Factors
- Genetic: >500 genes implicated; monogenic (channelopathies) and polygenic architectures.
- Structural/acquired: Stroke, TBI, CNS infections, tumors, cortical malformations, hypoxic-ischemic injury.
- Unknown: ~50% globally (higher in LMICs due to limited diagnostics).
Treatment Gap
~70% of people with epilepsy in LMICs receive no treatment (WHO). Barriers: cost, stigma, medication access, workforce shortage.
Genetic Disorders - Related Articles
- Presbyopia: Causes, Symptoms & Correction Options (Glasses, Contacts, Surgery)
- Genetics and Muscle Growth: How DNA Sets the Framework for Hypertrophy
- Understanding the Role of Genetics in Mental Health
- Early Puberty in Boys: Definition, Causes, and Evaluation
- Down Syndrome: Understanding Its Causes and Onset
- Gilbert's Syndrome: Understanding Symptoms, Causes & Management
- Diagnosing Mononucleosis: Clinical Evaluation, Monospot Test, CBC, and EBV-Specific Antibody Testing
